BioCryst Pharmaceuticals financials at a glance
| Year | Year | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.34M | $0.15M | $6.21M | $71.24M | $56.56M | $74.59M | $62.38M | $19.64M | $26.29M | $17.33M | $13.61M | $48.26M | $26.35M | $25.19M | $20.65M | $48.84M | $17.81M | $157.17M | $270.83M | $331.41M | $0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | -31.22% | -28.51% | -3.82% | -33.40% | -191.45% | -87.47% | -142.58% | -281.53% | -54.70% | -141.74% | -172.63% | 0.00% | -127.64% | 0.00% | -37.48% | 4.04% | 34.63% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | -45.31% | -48.03% | -18.42% | -53.42% | -252.44% | -122.20% | -177.24% | 0.00% | -81.74% | -184.45% | -227.95% | 0.00% | -203.66% | 0.00% | -113.08% | -54.81% | -29.81% | 0.00% |
| EPS | Earnings Per Share |
|
$-1.01 | $-1.50 | $-0.89 | $-0.65 | $-0.35 | $-0.73 | $-1.26 | $-0.75 | $-0.55 | $-0.68 | $-0.59 | $-0.75 | $-0.78 | $-0.98 | $-0.94 | $-1.09 | $-1.34 | $-1.33 | $-1.00 | $0.00 | |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | -0.00% | 0 | 0 | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 0 |
| Sha. | Shares |
|
21.73m | 26.45m | 29.23m | 37.95m | 38.26m | 43.83m | 44.92m | 45.21m | 50.88m | 59.09m | 71.86m | 73.34m | 73.76m | 98.4m | 109.64m | 154.06m | 176.57m | 177.65m | 184.35m | 204.81m | 204.81m |
| OCF | Operating Cash Flow |
|
$-18.15M | $-23.35M | $-15.21M | $-25.00M | $-20.87M | $-16.22M | $-28.56M | $-32.25M | $-37.40M | $-26.53M | $-38.55M | $-13.12M | $-53.44M | $-41.14M | $-92.57M | $-89.58M | $-137.22M | $-142.16M | $-161.85M | $-95.14M | $0.00M |
| FCF | Free Cash Flow |
|
$-18.43M | $-23.85M | $-16.61M | $-28.34M | $-22.08M | $-16.82M | $-28.89M | $-32.31M | $-37.51M | $-26.56M | $-38.66M | $-18.24M | $-60.96M | $-45.31M | $-92.68M | $-89.93M | $-164.61M | $-144.54M | $-163.20M | $-70.86M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-0.87 | $-0.93 | $-0.57 | $-0.86 | $-0.58 | $-0.43 | $-0.65 | $-0.72 | $-0.76 | $-0.48 | $-0.58 | $-0.25 | $-0.80 | $-0.49 | $-0.90 | $-0.78 | $-0.82 | $-0.81 | $-0.88 | $-0.51 | $0.00 |